共 50 条
- [31] Is There a Role for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis Due to Uterine Cancer? JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
- [33] Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis CIRUGIA ESPANOLA, 2015, 93 (08): : 496 - 501
- [34] Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin The AAPS Journal, 2016, 18 : 239 - 250
- [35] Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin Clinical Pharmacokinetics, 2013, 52 : 1111 - 1125
- [36] Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer Annals of Surgical Oncology, 2016, 23 : 3891 - 3898
- [38] Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin AAPS JOURNAL, 2016, 18 (01): : 239 - 250
- [39] The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
- [40] Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Annals of Surgical Oncology, 2016, 23 : 1941 - 1947